Probably the same level of expertise you bring to the table.
Amongst a number of reasons: the cytokine results from their NOXCOVID look pretty modest at best from what’s reported. mostly no change.
The STING theory hasn’t been adequately proved from what they’ve reported.
cytokines in non Covid sepsis/ARDS are much higher than in Covid. If Nox drug effect is so modest in affecting cytokines in Covid, I’m unconvinced it’ll do much in septic shock caused by other things.
if data later shows I’m wrong, fine.
Ann: Veyonda FDA Approved Trial to Commence, page-30
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $11.03K | 105.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 418372 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 102513 | 3 |
View Market Depth
| Last trade - 15.45pm 27/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |